Alembic Pharma looks technically constructive after a prolonged correction and base-building phase. The stock is now approaching a key resistance zone around ₹790–820 with improving price structure and gradual volume expansion. Look like accumulation at lower levels. A decisive breakout above the current consolidation range could trigger fresh momentum and trend reversal confirmation. I am adding this stock in my watchlist for further study.
Date 10/05/26
Disclaimer: I am not a SEBI registered investment advisor. The content is for educational purposes only and should not be considered financial advice. This is not any buy and sell recommendation. Please consult your financial advisor before making any investment decisions.
Date 10/05/26
Disclaimer: I am not a SEBI registered investment advisor. The content is for educational purposes only and should not be considered financial advice. This is not any buy and sell recommendation. Please consult your financial advisor before making any investment decisions.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.